Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Debora Joseph-Pietras"'
Autor:
Mark van Duin, Annemiek Broyl, Yvonne de Knegt, Hartmut Goldschmidt, Paul G. Richardson, Wim C. J. Hop, Bronno van der Holt, Debora Joseph-Pietras, George Mulligan, Rachel Neuwirth, Surinder S. Sahota, Pieter Sonneveld
Publikováno v:
Haematologica, Vol 96, Iss 11 (2011)
Background In multiple myeloma, expression of cancer testis antigens may provide prognostic markers and potential targets for immunotherapy. Expression at relapse has not yet been evaluated for a large panel of cancer testis antigens which can be cla
Externí odkaz:
https://doaj.org/article/90a566bd7eed46f486fe80674abf113d
Autor:
Sean H. Lim, Nicola Campbell, Beth Stuart, Marina Johnson, Debora Joseph-Pietras, Adam Kelly, Danielle Jeffrey, Anna H. Turaj, Kate Rolfvondenbaumen, Celine Galloway, Thomas Wynn, Adam R. Coleman, Benjamin Ward, Karen Long, Andrew T. Bates, Diana Ayres, Robert Lown, Janlyn Falconer, Oliver Brake, James Batchelor, Victoria Willimott, Anna Bowzyk Al-Naeeb, Lisa Robinson, Ann O’Callaghan, Graham P. Collins, Tobias Menne, Saul N. Faust, Christopher P. Fox, Matthew Ahearne, Peter W.M. Johnson, Andrew J. Davies, David Goldblatt
SUMMARYSARS-CoV-2 vaccination protects against COVID-19. Antibodies and antigen-specific T-cell responses against the spike domain can be used to measure vaccine immune response. Individuals with lymphoma have defects in humoral and cellular immunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05db81c23d3f376117b26a44fb620057
https://doi.org/10.1101/2021.12.08.21266760
https://doi.org/10.1101/2021.12.08.21266760
Autor:
Sean H. Lim, Beth Stuart, Debora Joseph-Pietras, Marina Johnson, Nicola Campbell, Adam Kelly, Danielle Jeffrey, Anna H. Turaj, Kate Rolfvondenbaumen, Celine Galloway, Thomas Wynn, Adam R. Coleman, Benjamin Ward, Karen Long, Helen Coleman, Carina Mundy, Andrew T. Bates, Diana Ayres, Robert Lown, Janlyn Falconer, Oliver Brake, James Batchelor, Victoria Willimott, Anna Bowzyk Al-Naeeb, Lisa Robinson, Ann O’Callaghan, Graham P. Collins, Tobias Menne, Saul N. Faust, Christopher P. Fox, Matthew Ahearne, Peter W. M. Johnson, Andrew J. Davies, David Goldblatt
Publikováno v:
Nature cancer. 3(5)
Patients with hematological malignancies are at increased risk of severe COVID-19 outcomes due to compromised immune responses, but the insights of these studies have been compromised due to intrinsic limitations in study design. Here we present the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e506cf0e53293f76d17683e1486ea5c1
https://pubmed.ncbi.nlm.nih.gov/35624336
https://pubmed.ncbi.nlm.nih.gov/35624336
Autor:
Ann O'Callaghan, Andrew Davies, Marina Johnson, Nicola Campbell, Graham P. Collins, Peter Johnson, Sean H. Lim, Matthew J. Ahearne, David Goldblatt, Debora Joseph-Pietras, Christopher P. Fox
Publikováno v:
The Lancet. Haematology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb3faf044c493add86f929abf52000bf
http://europepmc.org/articles/PMC8253538
http://europepmc.org/articles/PMC8253538
Autor:
Marina Johnson, Ann O'Callaghan, Andrew Davies, Nicola Campbell, Graham P. Collins, Debora Joseph-Pietras, Christopher P. Fox, Peter Johnson, Matthew J. Ahearne, David Goldblatt, Sean Hua Lim
Individuals with lymphoid malignancies have an increased mortality risk from COVID-19. Paradoxically, this population is least likely to be protected by SARS-CoV-2 vaccination as a result of disease- or treatment-related immunosuppression. Current da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00d64d2b21acd9b3c149eb1b24a2a3b1
https://doi.org/10.1101/2021.06.05.21258311
https://doi.org/10.1101/2021.06.05.21258311
Autor:
Graham P. Collins, C. Mundy, P. Johnson, B. Maynard, A. Bates, David Goldblatt, H. Coleman, Matthew J. Ahearne, S. N. Faust, R. Lown, J. Falconer, Mark H. Johnson, Debora Joseph-Pietras, V. Willimott, Ann O'Callaghan, D. Muller, N. Wetherall, N. Campbell, Andrew Davies, T. Wynn, Christopher P. Fox, Sean H. Lim
Publikováno v:
Hematological Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f77d99e4277c8e346ccd888e086ac0d
http://europepmc.org/articles/PMC8426672
http://europepmc.org/articles/PMC8426672
Autor:
Christian H. Ottensmeier, Sanjay Jogai, James A. R. Nicoll, Marc Hardwick, Edurne Arriola, Ian Galea, Luke Nolan, Debora Joseph-Pietras
Publikováno v:
Journal of the Neurological Sciences. 429:118843
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2794e13c1af0b8c8782fc04edfdfbc5
https://doi.org/10.1016/j.jns.2021.118843
https://doi.org/10.1016/j.jns.2021.118843
Autor:
Yvonne de Knegt, Surinder S. Sahota, Debora Joseph-Pietras, Annemiek Broyl, George Mulligan, Mark van Duin, Wim C. J. Hop, Hartmut Goldschmidt, Bronno van der Holt, Rachel Neuwirth, Paul G. Richardson, Pieter Sonneveld
Publikováno v:
Haematologica, 96(11), 1662-1669. Ferrata Storti Foundation
Background In multiple myeloma, expression of cancer testis antigens may provide prognostic markers and potential targets for immunotherapy. Expression at relapse has not yet been evaluated for a large panel of cancer testis antigens which can be cla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99ace0cd29a60ae167e7477dbbcc9067
https://doi.org/10.3324/haematol.2010.037978
https://doi.org/10.3324/haematol.2010.037978
Publikováno v:
Advances in Biology and Therapy of Multiple Myeloma ISBN: 9781461452591
New therapies in multiple myeloma (MM) now achieve disease remission in the majority of cases and open the possibility of immunotherapeutic intervention during the stage of minimal residual disease. Active vaccination provides considerable scope in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f52b40c4c07638c051add39ddc5a0c1
https://doi.org/10.1007/978-1-4614-5260-7_4
https://doi.org/10.1007/978-1-4614-5260-7_4
Publikováno v:
Journal of Cellular Biochemistry
Journal of Cellular Biochemistry, Wiley, 2010, 110 (4), pp.893-902
Journal of Cellular Biochemistry, Wiley, 2010, 110 (4), pp.893-902
Resveratrol, a naturally occurring polyphenol, has been shown to possess chemopreventive activities. In this study, we show that resveratrol (0-500 microM) inhibits the growth of a doxorubicin-resistant B16 melanoma cell subline (B16/DOX) (IC(50) = 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::118912aa37e1a00c30cca8d41148c342
https://hal.archives-ouvertes.fr/hal-00517821
https://hal.archives-ouvertes.fr/hal-00517821